Patent: 9,889,179
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 9,889,179
| Title: | FGF-18 compound dosing regimen |
| Abstract: | The present invention provides a new dosing regimen for administration of FGF-18 in the treatment of a cartilage disorder, such as osteoarthritis or cartilage injury. Specifically provided is a preferred treatment scheme comprising administrations every 3 weeks, 4 weeks or 5 weeks of an FGF-18 compound per treatment cycle. The new dosing regimen can include the co-adminsitration of an anti-inflammatory drug. |
| Inventor(s): | Ladel; Christoph H. (Darmstadt, DE), Guehring; Hans (Eltville, DE) |
| Assignee: | MERCK PATENT GMBH (Darmstadt, DE) |
| Application Number: | 15/120,131 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,889,179
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Swedish Orphan Biovitrum Ab (publ) | KINERET | anakinra | Injection | 103950 | 11/14/2001 | See Plans and Pricing | 2034-02-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
